Acute lymphocytic leukemia in children: maintenance therapy with methotrexat administered intermittently. Acute Leukemia Group B.
D000293:Adolescent; D000328:Adult; D001792:Blood Platelets; D001854:Bone Marrow Cells; D001856:Bone Marrow Examination; D002648:Child; D002675:Child, Preschool; D004417:Dyspnea; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006454:Hemoglobins; D006566:Herpesviridae Infections; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007239:Infections; D007273:Injections, Intramuscular; D007945:Leukemia, Lymphoid / Q000150:complications / Q000188:drug therapy*; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects; D009059:Mouth Diseases / Q000139:chemically induced; D009461:Neurologic Manifestations; D010024:Osteoporosis / Q000139:chemically induced; D011014:Pneumonia / Q000209:etiology; D011020:Pneumonia, Pneumocystis; D011239:Prednisolone / Q000627:therapeutic use; D012140:Respiratory Tract Diseases / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced; D014750:Vincristine / Q000627:therapeutic use
D006454:Hemoglobins; D014750:Vincristine; D011239:Prednisolone; D008727:Methotrexate